TRVI
USDTrevi Therapeutics Inc. Common Stock
$10.860+0.410 (3.923%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$10.450
High
$10.980
Low
$10.450
Volume
2.49M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.13M
Exchange
NGM
Currency
USD
52-Week Range
Low $2.36Current $10.860High $11.83
Related News
PR Newswire
Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine...
View more
Related Stocks
VANI
Vivani Medical Inc. (DE)
NASDAQ
Biotechnology: ...
ELUT
Elutia Inc.
NASDAQ
Biotechnology: ...
IAE
Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund Common Shares of Beneficial Interest
NASDAQ
Trusts Except E...
EVO
Evotec SE American Depositary Shares
NASDAQ
Biotechnology: ...
ENTX
Entera Bio Ltd. Ordinary Shares
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.